Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 4
2016 4
2017 2
2019 1
2020 3
2021 6
2022 5
2023 8
2024 5
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Drug-Related Hypercalcemia.
Lecoq AL, Livrozet M, Blanchard A, Kamenický P. Lecoq AL, et al. Endocrinol Metab Clin North Am. 2021 Dec;50(4):743-752. doi: 10.1016/j.ecl.2021.08.001. Endocrinol Metab Clin North Am. 2021. PMID: 34774245 Review.
[Post-COVID-19 syndrome].
Montani D, Savale L, Noel N, Meyrignac O, Colle R, Gasnier M, Corruble E, Beurnier A, Jutant EM, Pham T, Lecoq AL, Papon JF, Figuereido S, Harrois A, Humbert M, Monnet X; pour le Groupe d’étude Comebac. Montani D, et al. Among authors: lecoq al. Bull Acad Natl Med. 2023 Jun;207(6):812-820. doi: 10.1016/j.banm.2023.01.029. Epub 2023 Apr 25. Bull Acad Natl Med. 2023. PMID: 37292432 Free PMC article. Review. French.
Post-acute COVID-19 syndrome.
Montani D, Savale L, Noel N, Meyrignac O, Colle R, Gasnier M, Corruble E, Beurnier A, Jutant EM, Pham T, Lecoq AL, Papon JF, Figueiredo S, Harrois A, Humbert M, Monnet X; COMEBAC Study Group. Montani D, et al. Among authors: lecoq al. Eur Respir Rev. 2022 Mar 9;31(163):210185. doi: 10.1183/16000617.0185-2021. Print 2022 Mar 31. Eur Respir Rev. 2022. PMID: 35264409 Free PMC article. Review.
Management of X-linked hypophosphatemia in adults.
Lecoq AL, Brandi ML, Linglart A, Kamenický P. Lecoq AL, et al. Metabolism. 2020 Feb;103S:154049. doi: 10.1016/j.metabol.2019.154049. Epub 2019 Dec 18. Metabolism. 2020. PMID: 31863781 Review.
Primary hyperparathyroidism in pregnancy.
Kamenický P, Lecoq AL, Chanson P. Kamenický P, et al. Among authors: lecoq al. Ann Endocrinol (Paris). 2016 Jun;77(2):169-71. doi: 10.1016/j.ando.2016.04.010. Epub 2016 May 2. Ann Endocrinol (Paris). 2016. PMID: 27157105 Review.
Metabolically healthy obesity in adults with X-linked hypophosphatemia.
Lecoq AL, Schilbach K, Rocher L, Trabado S, Briot K, Herrou J, Forbes A, Garnier A, Piketty M, Bidlingmaier M, Rothenbuhler A, Linglart A, Carette C, Chaumet-Riffaud P, Kamenický P. Lecoq AL, et al. Eur J Endocrinol. 2024 Aug 5;191(2):156-165. doi: 10.1093/ejendo/lvae089. Eur J Endocrinol. 2024. PMID: 39120742
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Free article. Clinical Trial.
[Electrolyte disorders in oncological patients].
Saillant A, Try M, Laparra A, Lecoq AL, Zaidan M. Saillant A, et al. Among authors: lecoq al. Bull Cancer. 2024 Jul-Aug;111(7-8):687-700. doi: 10.1016/j.bulcan.2023.04.014. Epub 2023 May 17. Bull Cancer. 2024. PMID: 37208250 Review. French.
French expert consensus statement on diagnosis and MANAGEMENT of PRIMARY HYPERPARATHYROIDISM.
Vantyghem MC, Mirallié E, Al-Salameh A, Aubert S, Barraud S, Baud G, Hamou AB, Bertocchio JP, Borson-Chazot F, Bouillet B, Briet C, Buffet C, Caiazzo R, Cardot-Bauters C, Cariou B, Chabre O, Chanson P, Charbit J, Chéreau N, Chevalier B, Cirenei C, Coppin L, Corvillain B, Christou N, Cuny T, Deandreis D, Deguelte S, Delemer B, Desailloud R, Cao CD, Donatini G, Drui D, Dupeux M, Espiard S, Figueres L, Frey S, Ghanassia E, Ghander C, Gaujoux S, Goichot B, Groussin L, Gueorguieva I, Guérin C, Hadoux J, Haissaguerre M, Henry H, Hindié E, Houiller P, Jannin A, Kerlan V, Klein M, Koumakis E, Kuczma P, Ladsous M, Lasolle H, Bras ML, Lecoq AL, Lemaitre M, Lifante JC, Linglart A, Lopez AG, Lussey-Lepoutre C, Luton D, Maione L, Marciniak C, Mathonnet M, Menegaux F, Molin A, Mosbah H, Nominé-Criqui C, Odou MF, Osman D, Paladino NC, Picart C, Romanet P, Santucci N, Scheyer N, Sebag F, Sokol E, Taieb D, Tauveron I, Tresallet C, Triponez F, Vergès B, Vezzosi D, Brunaud L, Peter K. Vantyghem MC, et al. Among authors: lecoq al. Ann Endocrinol (Paris). 2025 Aug 30:102449. doi: 10.1016/j.ando.2025.102449. Online ahead of print. Ann Endocrinol (Paris). 2025. PMID: 40889554
39 results